Introduction

    Home

    Team

Project Overview

    Hacking Systems

    Human Pratices

    Lab Diary

    Safety

Plasmid Plug&Play

    Introduction

    Background

    Experiments

    Modeling

    Results

    Parts

Associative Memory
     Network

    Introduction

    Background

    Experiments

    Modeling

    Results

Extras

    SynbioBrasil

    USP and Unesp

    Attributions

    Sponsors

    Acknowledgements

    Photos

In vitro assay

This experiments was made to test if the loxP and the lox66 were working properly, it also allowed us to measure the Cre concentration needed in an in vitro recombination reaction. The particularity of lox66 is that it has an altered sequence at the end of it's left arm compared to loxP. This sequence variation reduces affinity of the Cre recombinase for the arm.

Based on the report made by the igem2010 UT-Tokyo team and some papers, the lox66 (BBa_I718016) from the registry was wrong, it had a gg instead a cg in its left arm.This part was corrected by the iGEM11_Tokyo_Tech team (BBa_K649206) and by the iGEM11_WITS_CSIR_SA team (BBa_K537019), but no DNA was available in the registry, so we decided to synthesized it and test it, using the proper sequence described by http://www.ncbi.nlm.nih.gov/pmc/articles/PMC137435/

Our experiment showed that 5U and 10U of Cre recombinase produce a reduction of linear DNA (Kanamycin resistance gene flanked with loxP and lox66) when compare with the control DNA (No Cre recombinase) and 1U of Cre recombinase, as is showed in the figure A. It also showed an increase in the plasmid form DNA (upper band at 2kb), as showed in figure B.

The conclusion is that we can use this loxP-lox66 mechanism in our design and we will need at least 5U of Cre recombinase for the in vitro experiments.

In vivo assay

We proved that we can circularize a fragment of DNA (Kanamycin resistance gene) flanked by a loxP and a lox66 sites in vitro. Later, we did a second experiment

codnkjjjjjjjjjjj

We found one colony growing in a LB plate with kanamycin, showing that the fusion was possible. Which is really a good result, because the pGEM plasmid has no RBS, so it is reported that it can be use to express but the expression is really low.

Based on the report made by the igem2010 UT-Tokyo team and some papers, the lox71 (BBa_I718017) from the registry was wrong, it had a cg instead a gc in its center sequence that is between the arms.

Apparently, this part was corrected by the iGEM11_WITS_CSIR_SA team (BBa_K537020), but the sequence from this group had the same error. The corrected part from iGEM11_Tokyo_Tech (BBa_K649205) was right but no DNA was available in the registry. So we decided to synthesized it and test it, using the proper sequence described by http://www.ncbi.nlm.nih.gov/pmc/articles/PMC137435/, and we submitted the correct DNA to the Registry.